BioAtla

$46.69
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$4.19 (-8.24%) As of 5:19 PM UTC today

Why Robinhood?

You can buy or sell BioAtla and other stocks, options, and ETFs commission-free!

About BCAB

BioAtla LLC develops conditionally active biologic antibody therapeutics. The firm's technologies include conditionally active biologics, comprehensive integrated antibody optimization, CPE and CPS, gigamab, and versitop. The company was founded by Jay M. Short and Carolyn Anderson in March 2007 and is headquartered in San Diego, CA. The listed name for BCAB is BioAtla, Inc. Common Stock.

CEO
Jay M. Short
Employees
—
Headquarters
San Diego, California
Founded
2007
Market Cap
1.64B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
309.29K
High Today
$52.48
Low Today
$45.81
Open Price
$52.48
Volume
177.64K
52 Week High
$58.40
52 Week Low
$27.15

BCAB Earnings

Q4 FY20
Estimated
— per share
Actual
Expected Mar 16, Pre-Market

You May Also Like

SLGL
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure